Conference abstractPublished 5 Dec 2016
Acute multifocal hemorrhagic retinal vasculitis in a child: A case report
An-Najah National University, Palestine; University of Alabama, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Background: Acute multifocal hemorrhagic retinal vasculitis (AMHRV) is a rare disease with unknown incidence that presents with abrupt onset of visual loss associated with retinal vasculitis, retinal hemorrhage, non-confluent posterior retinal infiltrates, vitreous cellular inflammation and papillitis in, otherwise, healthy adult individuals. The reported treatment options for acute multifocal hemorrhagic retinal vasculitis are oral corticosteroids, intravitreal ganciclovir and laser photocoagulation or vitrectomy. We report a child with acute multifocal hemorrhagic retinal vasculitis who was treated with aggressive immunosuppressive therapy resulting in a favorable visual outcome. Case Presentation: This is a retrospective case report of a 10-year-old African American girl who developed unilateral acute multifocal hemorrhagic retinal vasculitis, which later on progressed bilaterally. We conducted a review of the clinical, laboratory and photographic records to evaluate her functional and anatomic outcome after aggressive immunosuppressive treatment. During the first four months of treatment of OD with intravitreal ganciclovir, intravitreal dexamethasone and systemic prednisone, the change in vision in OD improved from light perception (LP) to counting fingers (CF). During the next 18 months of aggressive systemic treatment of OD and the newly affected left eye (OS), the change in vision improved from CF in OD and CF in OS to 20/200 in OD and 20/80 in OS. Management during the 18-month interval included rituximab infusions, cyclophosphamide/methylprednisolone infusions, prednisone and mycophenolate. Conclusions: This is the first reported case of acute multifocal hemorrhagic retinal vasculitis occurring in a child. Ophthalmologists should be aware of the need to treat severe acute multifocal hemorrhagic retinal vasculitis with aggressive immunosuppressive agents in collaboration with rheumatologists to obtain the best possible visual outcome.
Subjects
Ophthalmology & OptometryAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical and Experimental Ophthalmology
- SubjectOphthalmology & Optometry
- BylineArticles whose byline prints “Malik Y Ghannam”
- BylineArticles whose byline prints “Mohammed Naseemuddin”
- BylineArticles whose byline prints “Peter Weiser”
- BylineArticles whose byline prints “John O Mason”
